Baylor College of Medicine (BCM)
Dr Muñoz-Rivas (BCM) has dedicated the last 16 years to research and implementation of maternal immunization. She has been the Principal Investigator for several interventional clinical trials of vaccines in pregnant women, including RSV vaccine, pneumococcal, tetanus, Hemophilus influenza type b, seasonal influenza, H1N1 influenza and Tdap. She has carried out epidemiologic and safety studies of influenza vaccine in pregnancy. She has worked as a consultant with the US Centers for Disease Control and Prevention on Pandemic Preparedness in Pregnant women (before the 2009 pandemic); with the US National Institutes of Health in the development of guidelines and definitions for studies of vaccines in pregnancy under the Division of Microbiology and Infectious Diseases (2011-to date); with the American College of Obstetrics and Gynecology as a member of the Immunization Expert group since its inception in 2011; with the Brighton Collaboration as a member of the group which is developing definitions for the assessment of safety in studies of vaccines in pregnant women and neonates (since 2003); and more recently, with the World Health Organization and the Brighton Collaboration in the development and harmonization of definitions for the assessment of safety of immunization during pregnancy in mothers and infants (2014).
Contribution to the consortium
In WP 1, the focus will be on coordinating development of case definitions for key neonatal outcomes and terms. Dr Muñoz Rivas will drive simultaneous development and harmonization of outputs across several working groups creating this set of case definitions. In WP3, Dr Muñoz Rivas will be responsible for ensuring harmonization of the guidance document with the case definitions and terminology pertinent to key neonatal outcomes. As activity leader 1.3, Dr Muñoz Rivas will contribute to the overall scientific coordination as part of WP5.
Link to website: https://www.bcm.edu/people/view/b17b4582-ffed-11e2-be68-080027880ca6